Revenue increased 31.7%
Revenue changed +31.7% from the comparable as-filed period.
$1.4B→$1.8B1 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TEAM financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 351.9%
Operating income changed -351.9% from the comparable as-filed period.
-$12.5M→-$56.3M1 prior comparisons
Research & development increased 35.3%
Research & development changed +35.3% from the comparable as-filed period.
$685.3M→$927.0M1 prior comparisons
Net income decreased 39.0%
Net income changed -39.0% from the comparable as-filed period.
-$70.8M→-$98.4M1 prior comparisons
Operating margin moved 223 bp lower
Operating margin changed -223 basis points from the comparable as-filed period.
-0.92%→-3.15%1 prior comparisons
Gross profit increased 34.1%
Gross profit changed +34.1% from the comparable as-filed period.
$1.1B→$1.5B1 prior comparisons
Gross margin moved 149 bp higher
Gross margin changed +149 basis points from the comparable as-filed period.
83.81%→85.30%1 prior comparisons
SBC / revenue moved 271 bp lower
SBC / revenue changed -271 basis points from the comparable as-filed period.
25.56%→22.85%1 prior comparisons
Free-cash-flow proxy decreased 12.1%
Free-cash-flow proxy changed -12.1% from the comparable as-filed period.
$638.3M→$561.3M1 prior comparisons
Operating cash flow decreased 13.1%
Operating cash flow changed -13.1% from the comparable as-filed period.
$652.7M→$567.5M1 prior comparisons
Capital expenditure decreased 56.8%
Capital expenditure changed -56.8% from the comparable as-filed period.
$14.4M→$6.2M1 prior comparisons
Stock-based compensation increased 17.7%
Stock-based compensation changed +17.7% from the comparable as-filed period.
$346.8M→$408.3M1 prior comparisons
Capex / revenue moved 71 bp lower
Capex / revenue changed -71 basis points from the comparable as-filed period.
1.06%→0.35%1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.